Biotoxtech Price To Sales vs. Revenue

086040 Stock  KRW 4,285  170.00  3.82%   
Considering the key profitability indicators obtained from Biotoxtech's historical financial statements, Biotoxtech Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Biotoxtech's ability to earn profits and add value for shareholders.
For Biotoxtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotoxtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotoxtech Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotoxtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotoxtech Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Biotoxtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotoxtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotoxtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotoxtech Revenue vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biotoxtech's current stock value. Our valuation model uses many indicators to compare Biotoxtech value to that of its competitors to determine the firm's financial worth.
Biotoxtech Co is rated second in price to sales category among its peers. It is the top company in revenue category among its peers totaling about  10,918,926,981  of Revenue per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotoxtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotoxtech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Biotoxtech Revenue vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Biotoxtech

P/S

 = 

MV Per Share

Revenue Per Share

 = 
3.12 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Biotoxtech

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
34.09 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Biotoxtech Revenue vs Competition

Biotoxtech Co is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 1.27 Trillion. Biotoxtech holds roughly 34.09 Billion in revenue claiming about 2.68% of equities under Health Care industry.

Biotoxtech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biotoxtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotoxtech will eventually generate negative long term returns. The profitability progress is the general direction of Biotoxtech's change in net profit over the period of time. It can combine multiple indicators of Biotoxtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea. Biotoxtech is traded on Korean Securities Dealers Automated Quotations in South Korea.

Biotoxtech Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biotoxtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotoxtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotoxtech's important profitability drivers and their relationship over time.

Use Biotoxtech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotoxtech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotoxtech will appreciate offsetting losses from the drop in the long position's value.

Biotoxtech Pair Trading

Biotoxtech Co Pair Trading Analysis

The ability to find closely correlated positions to Biotoxtech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotoxtech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotoxtech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotoxtech Co to buy it.
The correlation of Biotoxtech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotoxtech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotoxtech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotoxtech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biotoxtech position

In addition to having Biotoxtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Most Shorted Equities Thematic Idea Now

Most Shorted Equities
Most Shorted Equities Theme
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 207 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Biotoxtech Stock

To fully project Biotoxtech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotoxtech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotoxtech's income statement, its balance sheet, and the statement of cash flows.
Potential Biotoxtech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biotoxtech investors may work on each financial statement separately, they are all related. The changes in Biotoxtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotoxtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.